Market Cap | 3.18B | P/E | - | EPS this Y | -2,366.70% | Ern Qtrly Grth | - |
Income | -57.05M | Forward P/E | 179.35 | EPS next Y | 129.70% | 50D Avg Chg | -5.00% |
Sales | 547.47M | PEG | -0.57 | EPS past 5Y | - | 200D Avg Chg | -13.00% |
Dividend | N/A | Price/Book | 7.31 | EPS next 5Y | 96.10% | 52W High Chg | -36.00% |
Recommedations | 2.00 | Quick Ratio | 1.38 | Shares Outstanding | 58.27M | 52W Low Chg | 6.00% |
Insider Own | 8.93% | ROA | -2.15% | Shares Float | 50.15M | Beta | 1.00 |
Inst Own | 93.74% | ROE | -13.28% | Shares Shorted/Prior | 4.46M/3.83M | Price | 55.60 |
Gross Margin | 87.15% | Profit Margin | -10.42% | Avg. Volume | 810,170 | Target Price | 64.93 |
Oper. Margin | -10.75% | Earnings Date | Oct 30 | Volume | 1,136,104 | Change | -1.75% |
Inari Medical, Inc. builds minimally invasive, novel, and catheter-based mechanical thrombectomy devices and accessories for the specific disease states in the United States. The company provides ClotTriever system, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; FlowTriever system, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases; InThrill system to treat small vessel thrombosis; and LimFlow system for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and risk of major amputation. It serves interventional radiologists, interventional cardiologists, and vascular surgeons. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.
Stifel | Hold | Sep 17, 24 |
Leerink Partners | Market Perform | Sep 3, 24 |
Piper Sandler | Neutral | Aug 26, 24 |
Deutsche Bank | Buy | Aug 9, 24 |
Wells Fargo | Overweight | Jul 31, 24 |
Truist Securities | Hold | Jul 31, 24 |
Canaccord Genuity | Buy | Jul 31, 24 |
Baird | Outperform | Jul 31, 24 |
Needham | Hold | Jul 31, 24 |
Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
---|---|---|---|---|---|---|---|---|
Hoffman William | Director Director | Dec 04 | Option | 0.43 | 103,492 | 44,502 | 1,070,493 | 12/06/23 |
Tu Thomas | Chief Medical Office.. Chief Medical Officer | Nov 16 | Sell | 59.87 | 25,451 | 1,523,751 | 320,932 | 11/17/23 |
Hykes Andrew | President and CEO President and CEO | Nov 16 | Sell | 59.87 | 37,448 | 2,242,012 | 434,817 | 11/17/23 |
Hoffman William | Director Director | Nov 15 | Sell | 60.75 | 25,000 | 1,518,750 | 967,001 | 11/17/23 |
Hill, Mitch C. | Chief Financial Offi.. Chief Financial Officer | Nov 13 | Sell | 56.2 | 6,500 | 365,300 | 170,230 | 11/15/23 |
Hill, Mitch C. | Chief Financial Offi.. Chief Financial Officer | Nov 13 | Option | 0.46 | 6,500 | 2,990 | 176,730 | 11/15/23 |
MILDER DONALD B | Director Director | Nov 07 | Buy | 53.07 | 56,100 | 2,977,227 | 3,031,714 | 11/08/23 |
Hoffman William | Director Director | Oct 16 | Sell | 56.32 | 25,000 | 1,408,000 | 992,001 | 10/18/23 |
Hill, Mitch C. | Chief Financial Offi.. Chief Financial Officer | Sep 12 | Sell | 67.55 | 6,500 | 439,075 | 171,802 | 09/14/23 |
Hill, Mitch C. | Chief Financial Offi.. Chief Financial Officer | Sep 12 | Option | 0.46 | 6,500 | 2,990 | 178,302 | 09/14/23 |
Hykes Andrew | President and CEO President and CEO | Aug 16 | Sell | 66.74 | 36,676 | 2,447,756 | 475,132 | 08/18/23 |
Tu Thomas | Chief Medical Office.. Chief Medical Officer | Aug 16 | Sell | 66.74 | 24,926 | 1,663,561 | 347,997 | 08/18/23 |
Hill, Mitch C. | Chief Financial Offi.. Chief Financial Officer | Jun 12 | Sell | 59.63 | 6,500 | 387,595 | 173,054 | 06/13/23 |
Hill, Mitch C. | Chief Financial Offi.. Chief Financial Officer | Jun 12 | Option | 0.46 | 6,500 | 2,990 | 179,554 | 06/13/23 |
Hoffman William | Director Director | May 15 | Sell | 70.28 | 106,897 | 7,512,721 | 1,120,643 | 05/18/23 |
Hykes Andrew | President and CEO President and CEO | May 16 | Sell | 70.03 | 36,676 | 2,568,420 | 513,608 | 05/18/23 |
Tu Thomas | Chief Medical Office.. Chief Medical Officer | May 16 | Sell | 70.03 | 24,927 | 1,745,638 | 373,727 | 05/18/23 |
Hoffman William | Director Director | Apr 17 | Sell | 64.72 | 25,000 | 1,618,000 | 1,227,540 | 04/19/23 |
Hill, Mitch C. | Chief Financial Offi.. Chief Financial Officer | Apr 12 | Sell | 64.76 | 12,750 | 825,690 | 179,304 | 04/14/23 |
Hill, Mitch C. | Chief Financial Offi.. Chief Financial Officer | Apr 12 | Option | 0.46 | 6,500 | 2,990 | 192,054 | 04/14/23 |
Hoffman William | Director Director | Mar 12 | Sell | 60.1 | 5,000 | 300,500 | 1,252,540 | 03/14/23 |
Hoffman William | Director Director | Mar 12 | Option | 0 | 961,350 | 1,257,540 | 03/14/23 | |
Tu Thomas | Chief Medical Office.. Chief Medical Officer | Feb 27 | Sell | 56.8 | 10,000 | 568,000 | 107,112 | 03/01/23 |
Tu Thomas | Chief Medical Office.. Chief Medical Officer | Feb 27 | Option | 0.46 | 10,000 | 4,600 | 117,112 | 03/01/23 |
Hykes Andrew | President and CEO President and CEO | Jan 20 | Sell | 62.01 | 9,000 | 558,090 | 93,046 | 01/24/23 |
Tu Thomas | Chief Medical Office.. Chief Medical Officer | Dec 27 | Sell | 64.24 | 10,000 | 642,400 | 86,451 | 12/28/22 |
Tu Thomas | Chief Medical Office.. Chief Medical Officer | Dec 27 | Option | 0.46 | 10,000 | 4,600 | 96,451 | 12/28/22 |
Hoffman William | President and CEO President and CEO | Dec 15 | Option | 0.43 | 55,000 | 23,650 | 292,481 | 12/16/22 |
Hoffman William | President and CEO President and CEO | Dec 15 | Sell | 67 | 55,000 | 3,685,000 | 237,481 | 12/16/22 |
Tu Thomas | Chief Medical Office.. Chief Medical Officer | Oct 27 | Sell | 76.21 | 10,000 | 762,100 | 96,451 | 10/28/22 |
MILDER DONALD B | Director Director | Sep 15 | Sell | 80.25 | 7,000 | 561,750 | 3,199,614 | 09/16/22 |
Hoffman William | President and CEO President and CEO | Sep 07 | Option | 0.43 | 30,000 | 12,900 | 408,901 | 09/09/22 |
Hoffman William | President and CEO President and CEO | Sep 07 | Sell | 72.02 | 46,308 | 3,335,102 | 362,593 | 09/09/22 |
Hykes Andrew | Chief Operating Offi.. Chief Operating Officer | Sep 06 | Sell | 70.00 | 5,000 | 350,000 | 130,991 | 09/08/22 |
Hoffman William | President and CEO President and CEO | Aug 05 | Option | 0.43 | 30,000 | 12,900 | 548,899 | 08/09/22 |
Hoffman William | President and CEO President and CEO | Aug 05 | Sell | 83 | 30,000 | 2,490,000 | 518,899 | 08/09/22 |
Hoffman William | President and CEO President and CEO | Jul 18 | Sell | 75.29 | 5,275 | 397,155 | 518,899 | 07/20/22 |
Hill, Mitch C. | Chief Financial Offi.. Chief Financial Officer | Jul 15 | Sell | 72.73 | 7,500 | 545,475 | 78,899 | 07/19/22 |
Hill, Mitch C. | Chief Financial Offi.. Chief Financial Officer | Jul 15 | Option | 0.46 | 7,500 | 3,450 | 86,399 | 07/19/22 |
Hoffman William | President and CEO President and CEO | Jul 08 | Sell | 75.58 | 11,237 | 849,292 | 524,174 | 07/12/22 |
Hoffman William | President and CEO President and CEO | Jul 06 | Option | 0.43 | 30,000 | 12,900 | 578,899 | 07/08/22 |
Hoffman William | President and CEO President and CEO | Jul 06 | Sell | 73.15 | 43,488 | 3,181,147 | 535,411 | 07/08/22 |
Hykes Andrew | Chief Operating Offi.. Chief Operating Officer | Jul 01 | Sell | 70.31 | 5,000 | 351,550 | 140,991 | 07/06/22 |
Hykes Andrew | Chief Operating Offi.. Chief Operating Officer | Jun 07 | Sell | 70.078 | 5,000 | 350,390 | 146,984 | 06/09/22 |
Tu Thomas | Chief Medical Office.. Chief Medical Officer | May 10 | Option | .457 | 30,000 | 13,710 | 107,819 | 05/12/22 |
MILDER DONALD B | Director Director | Apr 18 | Sell | 87.83 | 7,000 | 614,810 | 3,654,614 | 04/20/22 |
Hill, Mitch C. | Chief Financial Offi.. Chief Financial Officer | Apr 18 | Option | 0.46 | 7,500 | 3,450 | 87,062 | 04/20/22 |
Hill, Mitch C. | Chief Financial Offi.. Chief Financial Officer | Apr 18 | Sell | 87.8 | 7,500 | 658,500 | 79,562 | 04/20/22 |
Hykes Andrew | Chief Operating Offi.. Chief Operating Officer | Apr 01 | Sell | 91.22 | 10,000 | 912,200 | 156,984 | 04/05/22 |
ROOT JONATHAN D | Director Director | Jun 22 | Buy | 67.85 | 335 | 22,730 | 335 | 03/18/22 |